Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock

The role of drotrecogin alfa (activated) (DAA) in severe sepsis remains controversial and clinicians are unsure whether or not to treat their patients with DAA. In response to a request from the European Medicines Agency, Eli Lilly will sponsor a new placebo-controlled trial and history suggests the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Finfer, Simon, Ranieri, V. Marco, Thompson, B. Taylor, Barie, Philip S., Dhainaut, Jean-François, Douglas, Ivor S., Gårdlund, Bengt, Marshall, John C., Rhodes, Andrew
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer-Verlag 2008
Schlagworte:
Special Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2995439/
https://ncbi.nlm.nih.gov/pubmed/18839141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00134-008-1266-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge